Lenoir, NC May 31, 2019 – Exela Pharma Sciences is pleased to announce the approval and immediate launch of ELCYS™ (cysteine hydrochloride injection), USP, the only FDA Approved cysteine hydrochloride injection on the market in the United States.
On Friday, April 13, 2018, Phanesh Koneru, PhD, LLM, President and CEO of Exela Pharma Sciences interviewed the Honorable George W. Bush, 43rd President of the United States of America at the 9th Annual Becker’s Hospital Review conference in front of 4,000 attendees.
WINSTON-SALEM, NC – The North Carolina Manufacturing Extension Partnership (NCMEP), a public-private operating alliance working to help manufacturing companies become operationally efficient and well positioned to grow profitably, today announced the winners of its 2017 Manufacturing Leadership Awards at mfgCON in Winston-Salem, North Carolina.
Lenoir, NC July 5, 2016 – Exela Pharma Sciences today announced that it is the winner of 2016 Supplier Horizon Award in Pharmaceutical Services and Technology by Premier, Inc. (NASDAQ: PINC).
